EquityFlow
›
Companies
› Ethris
Ethris
Biotech
· Munich, DE ·
ethris.com
mRNA therapeutics platform for respiratory diseases
Funding history
Date
Round
Amount
Dec 2022
Funding round
Ethris agreed to raise EUR15M from Cipla EU to develop its mRNA-based respiratory therapeutics.
$15M
Investors
Cipla
Similar companies in Biotech
Imperagen
Haga Bioscience
Pixelgen Technologies
Gallant
Chai Discovery
SNIPR Biome
Cellbox Labs
Scope Biosciences
GenLumina
Actithera
NUCLIDIUM
Anocca
Explore funding flow on EquityFlow →